ctDNA positivity in NSCLC is associated with poorer survival and higher recurrence rates, highlighting its prognostic utility. ctDNA sequencing offers a non-invasive method for detecting minimal ...

The combination of intismeran autogene and Keytruda reduced recurrence or death risk by 49% in high-risk melanoma patients over five years. The study involved 157 patients with stage 3/4 melanoma who ...

Please provide your email address to receive an email when new articles are posted on . A novel AI multimodal model outperformed Oncotype DX in overall distant recurrence rate at 15 years. Additional ...

A tumor-informed ctDNA assay identified MRD in TNBC patients, indicating a 30-fold higher risk of distant recurrence for MRD-positive individuals. The NSABP B-59/GBG 96-GeparDouze trial involved 1550 ...

LONDON, Dec 10 (Reuters) - Roche (ROG.S), opens new tab said on Wednesday its experimental oral drug giredestrant reduced the risk of breast cancer recurrence by 30% compared with standard endocrine ...

In patients with paroxysmal AF, obstructive sleep apnea is associated with increased AF recurrence after ablation. Patients with paroxysmal atrial fibrillation (PAF) and baseline obstructive sleep ...

In a population-based cohort of 15- to 39-year-olds diagnosed with cancer, the risk for metastatic recurrence varied widely by cancer type and stage, and survival after recurrence was worse than after ...

1American University of Beirut Medical Center, Beirut, Lebanon.

LinkedIn support accidentally revealed its algorithm: it tracks "viewer tolerance," reducing visibility for authors whose posts are consistently ignored. To succeed, diversify content types weekly, ...

Breast cancer recurrence does happen, but thankfully the chance of it is low. Recurrence depends on factors like the type and stage of the original cancer, particularly whether the tumors are hormone ...

PTNB before surgery in stage 1 NSCLC patients is linked to higher local-regional recurrence and mortality rates. The study included 2026 patients, with 38.6% undergoing PTNB, showing higher recurrence ...